Psilocybin

A growing body of research suggests that psychedelic mushrooms, specifically those containing psilocybin, may have played a crucial role in the evolution of human consciousness. This conclusion aligns with the “Stoned Ape Hypothesis,” originally proposed by ethnobotanist Terence McKenna...

Psyence Biomedical Ltd. (NASDAQ:PBM) announced a major milestone on Monday with the initiation of the first clinical trial site in Australia for its Phase IIb study on nature-derived psilocybin as a potential treatment for Adjustment Disorder in patients receiving palliative care. This development...

Psilera, a Tampa-based biotech company, has taken a significant step in advancing treatments for dementia with its psilocybin-based drug, PSIL-006. Unlike traditional psychedelics, this pharmaceutical version of psilocybin is designed to avoid inducing the hallucinogenic effects commonly associated...

A new study reveals that athletes and sports staff in the U.S. and Canada are increasingly open to using psychedelic-assisted therapy (PAT) as a treatment for concussions and post-concussion symptoms. As reported by Double Blind, the research published in Therapeutic Advances in Psychopharmacology...

A recent open-label study conducted by the University of Copenhagen and the National Institute on Alcohol Abuse and Alcoholism has revealed that a single dose of psilocybin, a psychedelic compound found in magic mushrooms, could offer a novel and effective treatment for alcohol use disorder (AUD)....

Mike Tyson, the legendary heavyweight boxing champ, is once again in the spotlight not for his wild antics in the ring, but for his unconventional training regimen involving psychedelic mushrooms. As USA Today reported, during a recent appearance on Logan Paul’s podcast, Tyson revealed that...

The National Institutes of Health (NIH) is stepping up efforts to combat the rising tide of methamphetamine addiction by funding a $2.4 million study to explore the potential of psychedelics as a treatment. According to Marijuana Moment, this five-year grant, provided by the National Institute on...

A groundbreaking study published in Scientific Reports offers the most comprehensive analysis yet of how classic psychedelics, such as LSD and psilocybin, and the drug MDMA (commonly known as ecstasy) impact cognitive functions during and after use. As PsyPost reported, the research reveals that...

In response to the recent recall of Diamond Shruumz products, the nation’s leading non-profit advocating for the right to microdose, has intensified its call for a regulated microdosing industry. The Microdosing Collective (MC) stated in a press release that the recall, triggered by severe...

A federal appeals court heard arguments on Monday in a case that could significantly impact access to psilocybin for terminally ill patients. As reported by Marijuana Moment, the case brought by Dr. Sunil Aggarwal and his Advanced Integrated Medical Science (AIMS) Institute, challenges the Drug...

Colorado has finalized a comprehensive set of rules for the emerging psilocybin industry, marking a significant milestone in the state’s pioneering journey into legalized psychedelics. This regulatory framework, a product of nearly two years of meticulous planning, sets the stage for...

As reported in a recent press release, Incannex Healthcare Inc. (NASDAQ:IXHL) has received approval from the U.S. Food and Drug Administration to proceed with a phase 2 clinical trial investigating its psilocybin formulation, PSX-001, combined with psychotherapy for treating generalized anxiety...

A new study reveals how psilocybin, a compound in magic mushrooms induces dynamic hyperconnectivity in the brain, leading to profound ego-modifying experiences and feelings of oceanic boundlessness. Published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, this research delves...

In Mexico, a debate over the use of magic mushrooms is stirring, as ancient Indigenous traditions encounter modern scientific research and growing recreational demand. According to the Los Angeles Times, these fungi, revered in Mesoamerican rituals for centuries, are now at the center of a cultural...

The Magic Mushrooms and MDMA market is hitting new milestones. Canada has licensed Optimi Health Corp. (OTC:OPTHF) to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelic drugs market. This license allows the Vancouver-based startup to ship controlled...